Skip to main content
THC
NYSE Industrial Applications And Services

Tenet Healthcare Reports Strong Q1 Earnings, Raises Full-Year Guidance, and Repurchases $318M in Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$178.84
Mkt Cap
$15.778B
52W Low
$126.75
52W High
$247.21
52W Position info
41% above low
Off High info
28% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

THC sits 41% above its 52-week low of $126.75.

Summary

Tenet Healthcare reported a significant increase in Q1 net income and EPS, alongside strong cash flow and $318 million in share repurchases, while also providing an optimistic full-year 2026 outlook.


Key Events · Earnings and Guidance · THC

  • Strong First Quarter Financials

    Net income available to common shareholders surged 72.9% to $702 million, with diluted EPS rising 87.6% to $8.01 compared to the prior year. Adjusted diluted EPS increased 10.6% to $4.82.

  • Robust Cash Flow Generation

    Net cash flows provided by operating activities more than doubled to $1.641 billion, and adjusted free cash flow grew 44.2% to $978 million for the quarter.

  • Significant Share Repurchases

    The company repurchased 1.35 million shares of common stock for $318 million during the first quarter, reflecting strong capital allocation.

  • Updated Full-Year 2026 Outlook

    Tenet provided a comprehensive full-year outlook, projecting net operating revenues between $21.5 billion and $22.3 billion, and adjusted diluted EPS between $16.38 and $18.68.


Analysis · THC · Industrial Applications And Services

Tenet Healthcare delivered a strong first quarter, significantly increasing net income and diluted earnings per share, driven by robust operating cash flow and a favorable impact from the CommonSpirit Health agreement. The company also demonstrated a commitment to shareholder returns through substantial share repurchases. The updated full-year guidance provides a positive outlook, particularly for the Ambulatory Care segment, indicating continued operational strength and strategic execution.

At the time of this filing, THC was trading at $178.84 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $15.8B. The 52-week trading range was $126.75 to $247.21. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

THC - Latest Insights

THC
Jul 29, 2026, 4:27 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $255.00
Real-time Price: $255.00 info
Change: $0 (0%) info
Market Cap: $22.191B info
THC
Jul 23, 2026, 4:23 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $228.00
Real-time Price: $255.00 info
Change: +$27.00 (+12%) info
Market Cap: $22.191B info
THC
Jul 23, 2026, 4:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $209.38
Real-time Price: $255.00 info
Change: +$45.62 (+22%) info
Market Cap: $22.191B info
THC
Jul 23, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $199.05
Real-time Price: $255.00 info
Change: +$55.95 (+28%) info
Market Cap: $22.191B info
THC
Apr 30, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $177.12
Real-time Price: $255.00 info
Change: +$77.88 (+44%) info
Market Cap: $22.191B info